This article is more than 5 years old. Information may no longer be current.
WISE
Women’s Ischemia Syndrome Evaluation
Trial assessed whether evidence of myocardial ischemia occurs in the absence of obstructive coronary artery disease in women.
Design: diagnostic
Patients: 189
Centers: multicenter
Country: United States
RESULTS: During follow-up, 79 women (42%) had an adverse outcome, and there were 138 events, which included 11 deaths. An exploratory receiver-operator characteristic analysis suggested that coronary flow reserve <2.32 was the best discriminating threshold for adverse outcomes (event rate, 26.7%; and >2.32 event rate, 12.2%; P=.01). Lower coronary flow reserve was associated with increased risk for major adverse outcomes (HR=1.16; 95% CI, 1.04-1.30), a finding that held true among the 152 women without obstructive CAD (HR=1.20; 95% CI, 1.05-1.38).
Click here to read more about the WISE trial.
Published in: J Am Coll Cardiol. 2010;55:2825-2832.